Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sufentanil Sublingual Tablet for Acute Pain in ER
NCT02447848Phase 3Completed
- Sponsor
- Talphera
- Start
- Oct 2015
- Primary completion
- Jun 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of SurBred in acute pain, sponsored by Talphera. Started Oct 2015; status: completed.
02
Drugs
SurBred
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT02447848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02447848.